BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12362234)

  • 1. Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees.
    Moons AH; Peters RJ; Cate Ht; Bauer KA; Vlasuk GP; Büller HR; Levi M
    Thromb Haemost; 2002 Oct; 88(4):627-31. PubMed ID: 12362234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia.
    de Pont AC; Moons AH; de Jonge E; Meijers JC; Vlasuk GP; Rote WE; Büller HR; van der Poll T; Levi M
    J Thromb Haemost; 2004 Jan; 2(1):65-70. PubMed ID: 14717968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor/factor VIIa pathway mediates coagulation activation in induced-heat stroke in the baboon.
    Bouchama A; Al-Mohanna F; Assad L; Baturcam E; Eldali A; Owaidah T; Dehbi M
    Crit Care Med; 2012 Apr; 40(4):1229-36. PubMed ID: 22080642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant Nematode Anticoagulant Protein c2 following subcutaneous administration in man. Dependence on the stoichiometric binding to circulating factor X.
    Vlasuk GP; Bradbury A; Lopez-Kinninger L; Colón S; Bergum PW; Maki S; Rote WE
    Thromb Haemost; 2003 Nov; 90(5):803-12. PubMed ID: 14597974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice.
    Weijer S; Schoenmakers SH; Florquin S; Levi M; Vlasuk GP; Rote WE; Reitsma PH; Spek CA; van der Poll T
    J Infect Dis; 2004 Jun; 189(12):2308-17. PubMed ID: 15181580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxaemia induces resistance to activated protein C in healthy humans.
    de Pont AC; Bakhtiari K; Hutten BA; de Jonge E; Vlasuk GP; Rote WE; Levi M; Büller HR; Meijers JC
    Br J Haematol; 2006 Jul; 134(2):213-9. PubMed ID: 16846480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.
    Geisbert TW; Hensley LE; Jahrling PB; Larsen T; Geisbert JB; Paragas J; Young HA; Fredeking TM; Rote WE; Vlasuk GP
    Lancet; 2003 Dec; 362(9400):1953-8. PubMed ID: 14683653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
    Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
    Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
    Biemond BJ; Levi M; ten Cate H; Soule HR; Morris LD; Foster DL; Bogowitz CA; van der Poll T; Büller HR; ten Cate JW
    Thromb Haemost; 1995 Feb; 73(2):223-30. PubMed ID: 7792734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
    J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
    Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
    Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor.
    Lee AY; Vlasuk GP
    J Intern Med; 2003 Oct; 254(4):313-21. PubMed ID: 12974870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.
    Moons AH; Peters RJ; Bijsterveld NR; Piek JJ; Prins MH; Vlasuk GP; Rote WE; Büller HR
    J Am Coll Cardiol; 2003 Jun; 41(12):2147-53. PubMed ID: 12821239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: from unique mechanism to a promising new clinical anticoagulant.
    Vlasuk GP; Rote WE
    Trends Cardiovasc Med; 2002 Nov; 12(8):325-31. PubMed ID: 12536118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.
    Friederich PW; Levi M; Bauer KA; Vlasuk GP; Rote WE; Breederveld D; Keller T; Spataro M; Barzegar S; Büller HR
    Circulation; 2001 May; 103(21):2555-9. PubMed ID: 11382723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial.
    Giugliano RP; Wiviott SD; Stone PH; Simon DI; Schweiger MJ; Bouchard A; Leesar MA; Goulder MA; Deitcher SR; McCabe CH; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(25):2398-407. PubMed ID: 17599602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.
    Hembrough TA; Swartz GM; Papathanassiu A; Vlasuk GP; Rote WE; Green SJ; Pribluda VS
    Cancer Res; 2003 Jun; 63(11):2997-3000. PubMed ID: 12782609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Okamoto S; Okada Y
    Thromb Haemost; 1997 Oct; 78(4):1209-14. PubMed ID: 9364986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.